sp should be 5x imho, page-13

Well I totally agree with you Super and Frader.

I'm loving Imugene and always have, but PTX has enormous scope and is woefully overlooked and undervalued - just as Imugene was. I'm almost tempted to cross promote on the Imugene threads - which are attracting a lot of attention from newbies. Merely an incidental passing praise of PTX in the process of discussing Imugene, of course! lol.

Even CHM has a market cap 30% bigger than PTX, with one CAR T product still only in Phase 1 trials, and nothing much else. Good luck to them and I hope they take off - but PTX has a lot more going for it, in my view.

Anyway - good to see a bit off life returning to the PTX SP. I look forward to a future "Imugene day" for Prescient.

Cheers

Dave